These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26700247)
1. Both genetic deletion and pharmacological blockade of lysophosphatidic acid LPA1 receptor results in increased alcohol consumption. Castilla-Ortega E; Pavón FJ; Sánchez-Marín L; Estivill-Torrús G; Pedraza C; Blanco E; Suárez J; Santín L; Rodríguez de Fonseca F; Serrano A Neuropharmacology; 2016 Apr; 103():92-103. PubMed ID: 26700247 [TBL] [Abstract][Full Text] [Related]
2. Systemic blockade of LPA Sánchez-Marín L; Ladrón de Guevara-Miranda D; Mañas-Padilla MC; Alén F; Moreno-Fernández RD; Díaz-Navarro C; Pérez-Del Palacio J; García-Fernández M; Pedraza C; Pavón FJ; Rodríguez de Fonseca F; Santín LJ; Serrano A; Castilla-Ortega E Neuropharmacology; 2018 May; 133():189-201. PubMed ID: 29378212 [TBL] [Abstract][Full Text] [Related]
3. Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors. Pedraza C; Sánchez-López J; Castilla-Ortega E; Rosell-Valle C; Zambrana-Infantes E; García-Fernández M; Rodriguez de Fonseca F; Chun J; Santín LJ; Estivill-Torrús G Brain Struct Funct; 2014 Sep; 219(5):1659-72. PubMed ID: 23775489 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis. Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice. Kritikou E; van Puijvelde GH; van der Heijden T; van Santbrink PJ; Swart M; Schaftenaar FH; Kröner MJ; Kuiper J; Bot I Sci Rep; 2016 Nov; 6():37585. PubMed ID: 27883026 [TBL] [Abstract][Full Text] [Related]
6. Effects of genetic deletion versus pharmacological blockade of the LPA Moreno-Fernández RD; Nieto-Quero A; Gómez-Salas FJ; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Pérez-Martín M; Pedraza C Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30061118 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. David M; Machuca-Gayet I; Kikuta J; Ottewell P; Mima F; Leblanc R; Bonnelye E; Ribeiro J; Holen I; Vales RL; Jurdic P; Chun J; Clézardin P; Ishii M; Peyruchaud O J Biol Chem; 2014 Mar; 289(10):6551-6564. PubMed ID: 24429286 [TBL] [Abstract][Full Text] [Related]
8. LPA Wang F; Liu S; Pei J; Cai L; Liu N; Liang T; Dong X; Cong X; Chun J; Chen J; Hu S; Chen X Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260 [No Abstract] [Full Text] [Related]
9. Lysophosphatidic acid-induced increase in adult hippocampal neurogenesis facilitates the forgetting of cocaine-contextual memory. Ladrón de Guevara-Miranda D; Moreno-Fernández RD; Gil-Rodríguez S; Rosell-Valle C; Estivill-Torrús G; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Santín LJ; Castilla-Ortega E Addict Biol; 2019 May; 24(3):458-470. PubMed ID: 29480526 [TBL] [Abstract][Full Text] [Related]
10. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin. Ohashi T; Yamamoto T Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid and its receptor LPA Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid protects against acetaminophen-induced acute liver injury. Bae GH; Lee SK; Kim HS; Lee M; Lee HY; Bae YS Exp Mol Med; 2017 Dec; 49(12):e407. PubMed ID: 29217823 [TBL] [Abstract][Full Text] [Related]
14. Lentiviral vector-mediated dopamine d3 receptor modulation in the rat brain impairs alcohol intake and ethanol-induced conditioned place preference. Bahi A; Dreyer JL Alcohol Clin Exp Res; 2014 Sep; 38(9):2369-76. PubMed ID: 25257287 [TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis. Orosa B; García S; Martínez P; González A; Gómez-Reino JJ; Conde C Ann Rheum Dis; 2014 Jan; 73(1):298-305. PubMed ID: 23486415 [TBL] [Abstract][Full Text] [Related]
17. Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents. Harris RA; Bajo M; Bell RL; Blednov YA; Varodayan FP; Truitt JM; de Guglielmo G; Lasek AW; Logrip ML; Vendruscolo LF; Roberts AJ; Roberts E; George O; Mayfield J; Billiar TR; Hackam DJ; Mayfield RD; Koob GF; Roberto M; Homanics GE J Neurosci; 2017 Feb; 37(5):1139-1155. PubMed ID: 27986929 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice. Ueda H; Neyama H; Matsushita Y Cells; 2020 Aug; 9(8):. PubMed ID: 32824296 [TBL] [Abstract][Full Text] [Related]